Libra Infusions Limited reported earnings results for the year ended on June 30, 2017. The company has reported EPS of BDT 4.86, NAV per share of BDT 1,578.00 and NOCFPS of BDT 1.75 for the year ended on June 30, 2017 as against BDT 4.65, BDT 1,576.00 and BDT 56.49 respectively for the same period of the previous year.